Straub, T. J., Diao, L., Ford, C., Sims, M., Louie, T. J., Berenson, C., Kraft, C. S., Cohen, S. H., Cohen, S. H., Paskovaty, A., Lombardo, M., McGovern, B., von Moltke, L., & Henn, M. (n.d.). lB15. SER-109, an Investigational Microbiome Therapeutic, Reduces Abundance of Antimicrobial Resistance Genes in Patients with Recurrent Clostridioides difficile Infection (rCDI) after Standard-of-Care Antibiotics. Open forum infectious diseases, 8, S812–S813. http://access.bl.uk/ark:/81055/vdc_100150542630.0x000027